Stifel on Alkermes (ALKS): 'this still looks like a viable commercial product in NT2'
Tweet Send to a Friend
Stifel analyst Paul Matteis reiterated a Buy rating and $42.00 price target on Alkermes (NASDAQ: ALKS).The analyst comments "ALKS disclosed ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
